{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:06:14Z","timestamp":1792800374258,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203114"],"award-info":[{"award-number":["82203114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Research and development program of Shaanxi Province","award":["2024SF-YBXM-342"],"award-info":[{"award-number":["2024SF-YBXM-342"]}]},{"name":"Shaanxi Provincial Association for Science and Technology Young Talents Promotion Program","award":["20240342"],"award-info":[{"award-number":["20240342"]}]},{"name":"the Technology Incubation Fund and Talent Program Projects of Shaanxi Provincial People\u2019s Hospital","award":["2023JY-02"],"award-info":[{"award-number":["2023JY-02"]}],"id":[{"id":"https:\/\/ror.org\/009czp143","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14134-8","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T18:15:56Z","timestamp":1744654556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of m6 A-regulated ferroptosis biomarkers for prognosis in laryngeal cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"3","key":"14134_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"14134_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"14134_CR3","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1245\/s10434-021-10657-z","volume":"28","author":"J Han","year":"2021","unstructured":"Han J, Sumer BD. The Changing Demographics and Treatment of Larynx Cancer. Ann Surg Oncol. 2021;28(12):6927\u20138. https:\/\/doi.org\/10.1245\/s10434-021-10657-z.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"14134_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00432-021-03637-z","volume":"148","author":"K Deng","year":"2022","unstructured":"Deng K, Yao J, Zeng S, Wen M, Huang J, Zhu T, et al. The effect of surgery plus intensity-modulated radiotherapy on treatment in laryngeal cancer: A clinical retrospective study. J Cancer Res Clin Oncol. 2022;148(2):517\u201325. https:\/\/doi.org\/10.1007\/s00432-021-03637-z.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"14134_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12935-021-02021-8","volume":"21","author":"Y Huang","year":"2021","unstructured":"Huang Y, Gu M, Tang Y, Sun Z, Luo J, Li Z. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in laryngeal squamous cell cancer. Cancer Cell Int. 2021;21(1):316. https:\/\/doi.org\/10.1186\/s12935-021-02021-8.","journal-title":"Cancer Cell Int"},{"key":"14134_CR6","doi-asserted-by":"publisher","unstructured":"Hoesseini A, Dronkers EAC, Sewnaik A, Hardillo JAU, Baatenburg de Jong RJ, Offerman MPJ. Head and neck cancer patients' preferences for individualized prognostic information: a focus group study. BMC Cancer (2020) 20(1):399. \nhttps:\/\/doi.org\/10.1186\/s12885-020-6554-8.","DOI":"10.1186\/s12885-020-6554-8"},{"issue":"1","key":"14134_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10238-024-01538-2","volume":"25","author":"H Liu","year":"2024","unstructured":"Liu H, Wang P. CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance. Clin Exp Med. 2024;25(1):21.","journal-title":"Clin Exp Med"},{"key":"14134_CR8","doi-asserted-by":"crossref","unstructured":"Kowalski A, Malinowska K, Olszewski J, Zielinska-Blizniewska H. Expression of Programmed Death Receptor 1 (PD-1) Gene and Its Ligand (PD-L1) in Patients with Laryngeal Cancer. Biomolecules. 2021;11(7).","DOI":"10.3390\/biom11070970"},{"key":"14134_CR9","doi-asserted-by":"crossref","unstructured":"Mathew D, Marmarelis ME, Foley C, Bauml JM, Ye D, Ghinnagow R, et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science. 2024;384(6702):eadf1329.","DOI":"10.1126\/science.adf1329"},{"issue":"5","key":"14134_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19(5):306\u201327. https:\/\/doi.org\/10.1038\/s41571-022-00603-7.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"14134_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30(8):660\u20139. https:\/\/doi.org\/10.1038\/s41422-020-0343-4.","journal-title":"Cell Res"},{"issue":"3","key":"14134_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","volume":"83","author":"E Sendinc","year":"2023","unstructured":"Sendinc E, Shi Y. RNA m6A methylation across the transcriptome. Mol Cell. 2023;83(3):428\u201341. https:\/\/doi.org\/10.1016\/j.molcel.2023.01.006.","journal-title":"Mol Cell"},{"issue":"1","key":"14134_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12(1):121. https:\/\/doi.org\/10.1186\/s13045-019-0805-7.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"14134_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 2019;74(4):640\u201350. https:\/\/doi.org\/10.1016\/j.molcel.2019.04.025.","journal-title":"Mol Cell"},{"issue":"3","key":"14134_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020;37(3):270\u201388. https:\/\/doi.org\/10.1016\/j.ccell.2020.02.004.","journal-title":"Cancer Cell"},{"issue":"1","key":"14134_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-021-01871-4","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X, Tian L, Li Y, Wang J, Yan B, Yang L, et al. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res. 2021;40(1):80. https:\/\/doi.org\/10.1186\/s13046-021-01871-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"14134_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"issue":"4","key":"14134_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"14134_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334.","journal-title":"Cancer Cell"},{"issue":"5","key":"14134_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0.","journal-title":"Nat Rev Clin Oncol"},{"key":"14134_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747408","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Dai Z, Zheng L, Xu B, Zhang H, Fan F, et al. Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents\u2019 Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma. Front Immunol. 2021;12: 747408. https:\/\/doi.org\/10.3389\/fimmu.2021.747408.","journal-title":"Front Immunol"},{"key":"14134_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121110","volume":"277","author":"B Niu","year":"2021","unstructured":"Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, Wu C. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277: 121110. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121110.","journal-title":"Biomaterials"},{"issue":"7784","key":"14134_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392. https:\/\/doi.org\/10.1038\/s41586-019-1705-2.","journal-title":"Nature"},{"key":"14134_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66: 100916. https:\/\/doi.org\/10.1016\/j.drup.2022.100916.","journal-title":"Drug Resist Updat"},{"key":"14134_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103087","volume":"71","author":"H Li","year":"2024","unstructured":"Li H, Yu K, Hu H, Zhang X, Zeng S, Li J, et al. METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer. Redox Biol. 2024;71: 103087.","journal-title":"Redox Biol"},{"issue":"1","key":"14134_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, Xiu M, Wang J, Gao Y, Li Y. METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma. J Hematol Oncol. 2024;17(1):78.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"14134_CR27","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1002\/ijc.29649","volume":"137","author":"G Wichmann","year":"2015","unstructured":"Wichmann G, Rosolowski M, Krohn K, Kreuz M, Boehm A, Reiche A, et al. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int J Cancer. 2015;137(12):2846\u201357. https:\/\/doi.org\/10.1002\/ijc.29649.","journal-title":"Int J Cancer"},{"key":"14134_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.779153","volume":"11","author":"C Huang","year":"2021","unstructured":"Huang C, He J, Dong Y, Huang L, Chen Y, Peng A, Huang H. Identification of Novel Prognostic Markers Associated With Laryngeal Squamous Cell Carcinoma Using Comprehensive Analysis. Front Oncol. 2021;11: 779153. https:\/\/doi.org\/10.3389\/fonc.2021.779153.","journal-title":"Front Oncol"},{"issue":"7","key":"14134_CR29","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1111\/jcmm.16469","volume":"25","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang S, Yan X, Shan Y, Liu L, Zhou J, et al. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis. J Cell Mol Med. 2021;25(7):3634\u201345. https:\/\/doi.org\/10.1111\/jcmm.16469.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"14134_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"14134_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinformatics"},{"key":"14134_CR32","doi-asserted-by":"publisher","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) (2021) 2(3):100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"issue":"1","key":"14134_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"key":"14134_CR34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"issue":"11","key":"14134_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"key":"14134_CR36","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform (2021) 22(6). https:\/\/doi.org\/10.1093\/bib\/bbab260.","DOI":"10.1093\/bib\/bbab260"},{"key":"14134_CR37","doi-asserted-by":"publisher","unstructured":"Wang X, Yu B, Jin Q, Zhang J, Yan B, Yang L, et al. Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11\u2013159K7.2\/miR-206\/DNMT3A axis. J Cell Mol Med (2020) 24(12):6781\u201395. https:\/\/doi.org\/10.1111\/jcmm.15331.","DOI":"10.1111\/jcmm.15331"},{"issue":"1","key":"14134_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","volume":"22","author":"H Zhuang","year":"2023","unstructured":"Zhuang H, Yu B, Tao D, Xu X, Xu Y, Wang J, et al. The role of m6A methylation in therapy resistance in cancer. Mol Cancer. 2023;22(1):91. https:\/\/doi.org\/10.1186\/s12943-023-01782-2.","journal-title":"Mol Cancer"},{"key":"14134_CR39","doi-asserted-by":"publisher","first-page":"1132601","DOI":"10.3389\/fimmu.2023.1132601","volume":"14","author":"J Pan","year":"2023","unstructured":"Pan J, Huang T, Deng Z, Zou C. Roles and therapeutic implications of m6A modification in cancer immunotherapy. Front Immunol. 2023;14:1132601. https:\/\/doi.org\/10.3389\/fimmu.2023.1132601.","journal-title":"Front Immunol"},{"issue":"5","key":"14134_CR40","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41418-023-01138-9","volume":"30","author":"H Xia","year":"2023","unstructured":"Xia H, Wu Y, Zhao J, Cheng C, Lin J, Yang Y, et al. N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2. Cell Death Differ. 2023;30(5):1293\u2013304. https:\/\/doi.org\/10.1038\/s41418-023-01138-9.","journal-title":"Cell Death Differ"},{"issue":"5","key":"14134_CR41","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.7150\/ijbs.80921","volume":"19","author":"L Yang","year":"2023","unstructured":"Yang L, Yan B, Qu L, Ren J, Li Q, Wang J, et al. IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation. Int J Biol Sci. 2023;19(5):1382\u2013400. https:\/\/doi.org\/10.7150\/ijbs.80921.","journal-title":"Int J Biol Sci"},{"key":"14134_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.111002","volume":"114","author":"H Guo","year":"2023","unstructured":"Guo H, Han Q, Guan X, Li Z, Wang Y, He L, et al. M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3. Cell Signal. 2023;114: 111002. https:\/\/doi.org\/10.1016\/j.cellsig.2023.111002.","journal-title":"Cell Signal"},{"key":"14134_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147686","volume":"884","author":"J Li","year":"2023","unstructured":"Li J, Cao H, Yang J, Wang B. CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K\/AKT signal pathway. Gene. 2023;884: 147686. https:\/\/doi.org\/10.1016\/j.gene.2023.147686.","journal-title":"Gene"},{"key":"14134_CR44","doi-asserted-by":"publisher","unstructured":"Wang L, Dou X, Chen S, Yu X, Huang X, Zhang L, et al. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell (2023) 41(7):1294\u2013308 e8. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.019.","DOI":"10.1016\/j.ccell.2023.04.019"},{"key":"14134_CR45","unstructured":"Leung K. (89)Zr-Desferrioxamine B-Transferrin. Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD); 2004."},{"issue":"10","key":"14134_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22878","volume":"35","author":"P Cui","year":"2021","unstructured":"Cui P, Dai X, Liu R, Cao H. LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g\/TFRC. J Biochem Mol Toxicol. 2021;35(10): e22878. https:\/\/doi.org\/10.1002\/jbt.22878.","journal-title":"J Biochem Mol Toxicol"},{"key":"14134_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103157","volume":"72","author":"L Wu","year":"2024","unstructured":"Wu L, Du Y, Wang L, Zhang Y, Ren J. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis. Redox Biol. 2024;72: 103157.","journal-title":"Redox Biol"},{"issue":"1","key":"14134_CR48","doi-asserted-by":"publisher","first-page":"15398","DOI":"10.1038\/s41598-024-64517-3","volume":"14","author":"B Du","year":"2024","unstructured":"Du B, Wang P, Wei L, Qin K, Pei Z, Zheng J, et al. Unraveling the independent role of METTL3 in m6A modification and tumor progression in esophageal squamous cell carcinoma. Sci Rep. 2024;14(1):15398.","journal-title":"Sci Rep"},{"key":"14134_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102493","volume":"57","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen S, Wei S, Cheng S, Shi R, Zhao R, et al. CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biol. 2022;57: 102493. https:\/\/doi.org\/10.1016\/j.redox.2022.102493.","journal-title":"Redox Biol"},{"key":"14134_CR50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12935-024-03287-4","volume":"24","author":"Z Yan","year":"2024","unstructured":"Yan Z, Duan C, Li X, Wang H, Li S, Zhou X, Miao Y. circ-TFRC downregulation suppresses ovarian cancer progression via miR-615-3p\/IGF2 axis regulation. Cancer Cell Int. 2024;24:152. https:\/\/doi.org\/10.1186\/s12935-024-03287-4.","journal-title":"Cancer Cell Int"},{"key":"14134_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41419-023-06114-2","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Zhou Y, Ning L, Chen J, Chen H, Li X. Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer. Cell Death Dis. 2023;14:588. https:\/\/doi.org\/10.1038\/s41419-023-06114-2.","journal-title":"Cell Death Dis"},{"key":"14134_CR52","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/cam4.267","volume":"3","author":"K Nagai","year":"2014","unstructured":"Nagai K, Nakahata S, Shimosaki S, Tamura T, Kondo Y, Baba T, et al. Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer. Cancer Med. 2014;3:1085\u201399. https:\/\/doi.org\/10.1002\/cam4.267. Epub 2014 Jun 2.","journal-title":"Cancer Med"},{"key":"14134_CR53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbrc.2015.11.110","volume":"469","author":"C Cheng","year":"2016","unstructured":"Cheng C, Yue W, Li L, Li S, Gao C, Si L, Tian H. Regulator of G-protein signaling 4: A novel tumor suppressor with prognostic significance in non-small cell lung cancer. Biochem Biophys Res Commun. 2016;469:384\u201391. https:\/\/doi.org\/10.1016\/j.bbrc.2015.11.110.","journal-title":"Biochem Biophys Res Commun"},{"key":"14134_CR54","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.7314\/apjcp.2012.13.4.1097","volume":"13","author":"XM Mu","year":"2012","unstructured":"Mu XM, Shi W, Sun LX, Li H, Wang YR, Jiang ZZ, Zhang LY. Pristimerin inhibits breast cancer cell migration by up- regulating regulator of G protein signaling 4 expression. Asian Pac J Cancer Prev. 2012;13:1097\u2013104. https:\/\/doi.org\/10.7314\/apjcp.2012.13.4.1097.","journal-title":"Asian Pac J Cancer Prev"},{"key":"14134_CR55","first-page":"4577","volume":"21","author":"XX Liu","year":"2017","unstructured":"Liu XX, Gong HF, Zhao XX. Correlation of RGS4 and P16 expressions with pediatric nephroblastoma and its significance on prognosis. Eur Rev Med Pharmacol Sci. 2017;21:4577\u201383.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"14134_CR56","doi-asserted-by":"publisher","unstructured":"Guda MR, Velpula KK, Asuthkar S, Cain CP, Tsung AJ. Targeting RGS4 Ablates Glioblastoma Proliferation. Int J Mol Sci. 2020; 21. https:\/\/doi.org\/10.3390\/ijms21093300.","DOI":"10.3390\/ijms21093300"},{"key":"14134_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00702-023-02604-x","volume":"130","author":"A Verma","year":"2023","unstructured":"Verma A, Kommaddi RP, Gnanabharathi B, Hirsch EC, Ravindranath V. Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson\u2019s disease. J Neural Transm (Vienna). 2023;130:495\u2013512. https:\/\/doi.org\/10.1007\/s00702-023-02604-x.","journal-title":"J Neural Transm (Vienna)"},{"key":"14134_CR58","doi-asserted-by":"publisher","first-page":"1252064","DOI":"10.3389\/fcell.2024.1252064","volume":"12","author":"Q Liu","year":"2024","unstructured":"Liu Q, Lv L, Cai X, Zhu J, Li J, Yang L, et al. Correlation between RNA N6-methyladenosine and ferroptosis in cancer: current status and prospects. Front Cell Dev Biol. 2024;12:1252064.","journal-title":"Front Cell Dev Biol"},{"key":"14134_CR59","doi-asserted-by":"crossref","unstructured":"Guda MR, Velpula KK, Asuthkar S, Cain CP, Tsung AJ. Targeting RGS4 Ablates Glioblastoma Proliferation. Int J Mol Sci. 2020;21(9).","DOI":"10.3390\/ijms21093300"},{"key":"14134_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biochi.2014.07.019","volume":"106","author":"M Arenas-Salinas","year":"2014","unstructured":"Arenas-Salinas M, Townsend PD, Brito C, Marquez V, Marabolli V, Gonzalez-Nilo F, et al. The crystal structure of ferritin from Chlorobium tepidum reveals a new conformation of the 4-fold channel for this protein family. Biochimie. 2014;106:39\u201347. https:\/\/doi.org\/10.1016\/j.biochi.2014.07.019.","journal-title":"Biochimie"},{"key":"14134_CR61","doi-asserted-by":"publisher","unstructured":"Liu S, Yan S, Zhu J, Lu R, Kang C, Tang K, et al. Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab. Int J Mol Sci (2022) 23(16). https:\/\/doi.org\/10.3390\/ijms23169014.","DOI":"10.3390\/ijms23169014"},{"key":"14134_CR62","doi-asserted-by":"publisher","first-page":"2349429","DOI":"10.1080\/15384047.2024.2349429","volume":"25","author":"L Li","year":"2024","unstructured":"Li L, Zeng J, He S, Yang Y, Wang C. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer. Cancer Biol Ther. 2024;25:2349429. https:\/\/doi.org\/10.1080\/15384047.2024.2349429.","journal-title":"Cancer Biol Ther"},{"key":"14134_CR63","doi-asserted-by":"crossref","unstructured":"Shu L, Huang X, Cheng X, Li X. Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration. Cells. 2021;10(10).","DOI":"10.3390\/cells10102694"},{"issue":"6","key":"14134_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188967","volume":"1878","author":"S Singh","year":"2023","unstructured":"Singh S, Sadhukhan S, Sonawane A. 20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight. Biochim Biophys Acta Rev Cancer. 2023;1878(6): 188967.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"14134_CR65","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s00520-025-09317-9","volume":"33","author":"RJ Chan","year":"2025","unstructured":"Chan RJ, Walker A, Vardy J, Chan A, Oppegaard K, Conley YP, et al. Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment. Support Care Cancer. 2025;33(4):254.","journal-title":"Support Care Cancer"},{"key":"14134_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.756895","volume":"9","author":"C Yang","year":"2022","unstructured":"Yang C, Li J, Guo Y, Gan D, Zhang C, Wang R, et al. Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma. Front Mol Biosci. 2022;9: 756895. https:\/\/doi.org\/10.3389\/fmolb.2022.756895.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"14134_CR67","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.ygeno.2021.04.012","volume":"113","author":"Y Hu","year":"2021","unstructured":"Hu Y, Zheng M, Wang S, Gao L, Gou R, Liu O, et al. Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer. Genomics. 2021;113(4):2134\u201344. https:\/\/doi.org\/10.1016\/j.ygeno.2021.04.012.","journal-title":"Genomics"},{"key":"14134_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.727762","volume":"9","author":"ZW Hu","year":"2021","unstructured":"Hu ZW, Wen YH, Ma RQ, Chen L, Zeng XL, Wen WP, Sun W. Ferroptosis Driver SOCS1 and Suppressor FTH1 Independently Correlate With M1 and M2 Macrophage Infiltration in Head and Neck Squamous Cell Carcinoma. Front Cell Dev Biol. 2021;9: 727762. https:\/\/doi.org\/10.3389\/fcell.2021.727762.","journal-title":"Front Cell Dev Biol"},{"key":"14134_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cancergen.2023.03.002","volume":"274\u2013275","author":"H Liu","year":"2023","unstructured":"Liu H. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma. Cancer Genet. 2023;274\u2013275:21\u20135.","journal-title":"Cancer Genet"},{"key":"14134_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108302","volume":"240","author":"H Liu","year":"2022","unstructured":"Liu H, Dilger JP, Lin J. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacol Ther. 2022;240: 108302.","journal-title":"Pharmacol Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14134-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T03:26:44Z","timestamp":1750735604000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14134-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14134"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14134-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The affiliations 1-3 have been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the protocol approved by the Ethical Review Committee of the Second Affiliated Hospital of Harbin Medical University and Shaanxi Provincial People's Hospital, patient tissue samples were obtained with informed consent. All patients provided signed informed consent (2022\u2013K268).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"694"}}